Citation Impact
Citing Papers
Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature
2010
The clinical symptoms of Parkinson's disease
2016 Standout
The Role of Oxidative Stress in Parkinson's Disease
2013
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Parkinson disease
2017 Standout
Parkinson's disease
2021 Standout
Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences
2006
eIF4E – from translation to transformation
2004
AKT/PKB Signaling: Navigating Downstream
2007 Standout
Transcranial Sonography for the Discrimination of Idiopathic Parkinson’s Disease from the Atypical Parkinsonian Syndromes
2010
Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study
2009
The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis
2016
Spermine and spermidine mediate protection against oxidative damage caused by hydrogen peroxide
2007
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Amino acids: metabolism, functions, and nutrition
2009 Standout
Incidence of Parkinson's disease and parkinsonism in northern Sweden: A population‐based study
2010
Dietary Polyamine Intake and Polyamines Measured in Urine
2014
Parkinson's disease
2009 Standout
Are delayed‐start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?
2008
Epidemiology of Parkinson’s disease
2017 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Alzheimer's disease
2015
Parkinson's disease
2015 Standout
Metabolomics: beyond biomarkers and towards mechanisms
2016 Standout
White matter integrity, fiber count, and other fallacies: The do's and don'ts of diffusion MRI
2012 Standout
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Gut microbiota, metabolites and host immunity
2016 Standout
β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO)
2009 Standout
Sex differences in Parkinson’s disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics
2017
Emerging Concepts in Targeting the Polyamine Metabolic Pathway in Epithelial Cancer Chemoprevention and Chemotherapy
2006
The therapeutic potential of monoamine oxidase inhibitors
2006
Short-chain fatty acids in control of body weight and insulin sensitivity
2015 Standout
Polyamines and cancer: old molecules, new understanding
2004
A Bayesian model of shape and appearance for subcortical brain segmentation
2011 Standout
Single-cell transcriptomic analysis of Alzheimer’s disease
2019 StandoutNature
MRI characteristics of the substantia nigra in Parkinson's disease: A combined quantitative T1 and DTI study
2009
Socioeconomic status in relation to Parkinson's disease risk and mortality
2016
Spermidine/Spermine N1-Acetyltransferase-1 Binds to Hypoxia-inducible Factor-1α (HIF-1α) and RACK1 and Promotes Ubiquitination and Degradation of HIF-1α
2007 StandoutNobel
Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes
2004 StandoutNobel
Industry sponsorship and research outcome
2012 Standout
Reporting of Conflicts of Interest in Meta-analyses of Trials of Pharmacological Treatments
2011
Mortality in Parkinson's disease: A systematic review and meta‐analysis
2014
The neuropathological diagnosis of Alzheimer’s disease
2019 Standout
Gut Microbiota is Altered in Patients with Alzheimer’s Disease
2018 Standout
Accuracy of clinical diagnosis of Parkinson disease
2016
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial
2014
Spermidine in health and disease
2018 StandoutScience
Health‐related quality of life in early Parkinson's disease: The impact of nonmotor symptoms
2013
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology
2017 Standout
Identification of a New Endogenous Metabolite and the Characterization of Its Protein Interactions through an Immobilization Approach
2008 StandoutNobel
Development and validation of prognostic survival models in newly diagnosed Parkinson's disease
2017
Parkinson's disease incidence and prevalence assessment in F rance using the national healthcare insurance database
2014
A perspective of polyamine metabolism
2003
Distinct Signaling Events Downstream of mTOR Cooperate To Mediate the Effects of Amino Acids and Insulin on Initiation Factor 4E-Binding Proteins
2005 StandoutNobel
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
2019 Standout
Dysregulation of the TSC-mTOR pathway in human disease
2004 Standout
Industry sponsorship and research outcome
2017 Standout
Fluorination in Medicinal Chemistry: Methods, Strategies, and Recent Developments
2008 Standout
The role of spermidine/spermineN1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells
2007
Works of Robert Caslake being referenced
Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in North East Scotland: The PINE study
2013
Polyamines and colon cancer
2001
Age-, and gender-specific incidence of vascular parkinsonism, progressive supranuclear palsy, and parkinsonian-type multiple system atrophy in North East Scotland: The PINE study
2014
Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism
2008
Changes in quality of life in people with Parkinson's disease left untreated at diagnosis
2007
Monoamine oxidase B inhibitors for early Parkinson's disease
2005
Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease
2009